375 related articles for article (PubMed ID: 16902180)
1. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
Seta K; Sadoshima J
J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
Kagiyama S; Matsumura K; Fukuhara M; Sakagami K; Fujii K; Iida M
Hypertens Res; 2007 Oct; 30(10):979-89. PubMed ID: 18049031
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.
Zhai P; Yamamoto M; Galeotti J; Liu J; Masurekar M; Thaisz J; Irie K; Holle E; Yu X; Kupershmidt S; Roden DM; Wagner T; Yatani A; Vatner DE; Vatner SF; Sadoshima J
J Clin Invest; 2005 Nov; 115(11):3045-56. PubMed ID: 16276415
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
11. Elevated dietary sodium intake exacerbates myocardial hypertrophy associated with cardiac-specific overproduction of angiotensin II.
Porrello ER; Huggins CE; Curl CI; Domenighetti AA; Pedrazzini T; Delbridge LM; Morgan TO
J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):169-75. PubMed ID: 15806712
[TBL] [Abstract][Full Text] [Related]
12. Hijacking epidermal growth factor receptors by angiotensin II: new possibilities for understanding and treating cardiac hypertrophy.
Smith NJ; Chan HW; Osborne JE; Thomas WG; Hannan RD
Cell Mol Life Sci; 2004 Nov; 61(21):2695-703. PubMed ID: 15549170
[TBL] [Abstract][Full Text] [Related]
13. Galphaq expression activates EGFR and induces Akt mediated cardiomyocyte survival: dissociation from Galphaq mediated hypertrophy.
Howes AL; Miyamoto S; Adams JW; Woodcock EA; Brown JH
J Mol Cell Cardiol; 2006 May; 40(5):597-604. PubMed ID: 16466740
[TBL] [Abstract][Full Text] [Related]
14. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
[TBL] [Abstract][Full Text] [Related]
15. Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium.
Itoh S; Ding B; Shishido T; Lerner-Marmarosh N; Wang N; Maekawa N; Berk BC; Takeishi Y; Yan C; Blaxall BC; Abe J
Circulation; 2006 Apr; 113(14):1787-98. PubMed ID: 16585392
[TBL] [Abstract][Full Text] [Related]
16. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
Chen J; Chen JK; Neilson EG; Harris RC
J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
[TBL] [Abstract][Full Text] [Related]
17. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
Huggins CE; Domenighetti AA; Pedrazzini T; Pepe S; Delbridge LM
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):186-90. PubMed ID: 14608525
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism.
You W; Min X; Zhang X; Qian B; Pang S; Ding Z; Li C; Gao X; Di R; Cheng Y; Liu L
Shock; 2009 Jul; 32(1):108-17. PubMed ID: 19106822
[TBL] [Abstract][Full Text] [Related]
20. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
